RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies

The SARS-CoV-2 pandemic still represents a threat for immunosuppressed and hematological malignancy (HM) bearing patients, causing increased morbidity and mortality. Given the low anti-SARSCoV-2 IgG titers post-vaccination, the COVID-19 threat prompted the prophylactic use of engineered anti-SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bigenwald, Camille, Haddad, Yacine, Thelemaque, Cassandra, Carrier, Agathe, Birebent, Roxanne, Ly, Pierre, Flament, Caroline, Lahmar, Imran, de Sousa, Eric, Maeurer, Markus, Miyara, Makoto, Assi, Tarek, Castilla-Llorente, Cristina, Willekens, Christophe, Fayemi, Céline, Lazarovici, Julien, Marabelle, Aurélien, Derosa, Lisa, Ribrag, Vincent, Zitvogel, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828759/
https://www.ncbi.nlm.nih.gov/pubmed/36632566
http://dx.doi.org/10.1080/2162402X.2022.2163785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828759/
https://www.ncbi.nlm.nih.gov/pubmed/36632566
http://dx.doi.org/10.1080/2162402X.2022.2163785

Ejemplares similares